{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:19Z","timestamp":1792593679316,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973858"],"award-info":[{"award-number":["81973858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973858"],"award-info":[{"award-number":["81973858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04428-7","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:34:45Z","timestamp":1784968485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High xCT expression indicates poor prognosis and chemoradiotherapy resistance in rectal cancer patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Yingru","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"LiuFu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canfeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"3","key":"4428_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4428_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736.","journal-title":"Gut"},{"issue":"12","key":"4428_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713\u201332. https:\/\/doi.org\/10.1038\/s41575-019-0189-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10207","key":"4428_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)32319-0.","journal-title":"Lancet"},{"issue":"4","key":"4428_CR5","doi-asserted-by":"publisher","first-page":"e185896","DOI":"10.1001\/jamaoncol.2018.5896","volume":"5","author":"JJ Smith","year":"2019","unstructured":"Smith JJ, Strombom P, Chow OS, et al. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. JAMA Oncol. 2019;5(4):e185896. https:\/\/doi.org\/10.1001\/jamaoncol.2018.5896.","journal-title":"JAMA Oncol"},{"issue":"1","key":"4428_CR6","doi-asserted-by":"publisher","first-page":"e215445","DOI":"10.1001\/jamaoncol.2021.5445","volume":"8","author":"E Fokas","year":"2022","unstructured":"Fokas E, Schlenska-Lange A, Polat B, et al. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO\/ARO\/AIO-12 Randomized Clinical Trial. JAMA Oncol. 2022;8(1):e215445. https:\/\/doi.org\/10.1001\/jamaoncol.2021.5445.","journal-title":"JAMA Oncol"},{"issue":"9","key":"4428_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/s1470-2045(10)70172-8","volume":"11","author":"M Maas","year":"2010","unstructured":"Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835\u201344. https:\/\/doi.org\/10.1016\/s1470-2045(10)70172-8.","journal-title":"Lancet Oncol"},{"key":"4428_CR8","doi-asserted-by":"publisher","unstructured":"Cui H, Liang W, Cui J, et al. Safety and feasibility of minimally invasive gastrectomy after neoadjuvant immunotherapy for locally advanced gastric cancer: a propensity score-matched analysis in China. Gastroenterol Rep. 2024;12. https:\/\/doi.org\/10.1093\/gastro\/goae005.","DOI":"10.1093\/gastro\/goae005"},{"key":"4428_CR9","doi-asserted-by":"publisher","unstructured":"Fokas E, Str\u00f6bel P, Fietkau R, et al. Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. J Natl Cancer Inst. 2017;109(12). https:\/\/doi.org\/10.1093\/jnci\/djx095.","DOI":"10.1093\/jnci\/djx095"},{"issue":"5","key":"4428_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, Hewett SJ, Huang Y, et al. The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(5):522\u201355. https:\/\/doi.org\/10.1089\/ars.2011.4391.","journal-title":"Antioxid Redox Signal"},{"key":"4428_CR11","doi-asserted-by":"publisher","first-page":"15074","DOI":"10.1038\/ncomms15074","volume":"8","author":"CS Shin","year":"2017","unstructured":"Shin CS, Mishra P, Watrous JD, et al. The glutamate\/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat Commun. 2017;8:15074. https:\/\/doi.org\/10.1038\/ncomms15074.","journal-title":"Nat Commun"},{"issue":"10","key":"4428_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy P, Gyimesi G, Kanai Y, et al. Amino acid transporters revisited: New views in health and disease. Trends Biochem Sci. 2018;43(10):752\u201389. https:\/\/doi.org\/10.1016\/j.tibs.2018.05.003.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"4428_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang Y, Zhuang L, et al. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018;38(1):12. https:\/\/doi.org\/10.1186\/s40880-018-0288-x.","journal-title":"Cancer Commun (Lond)"},{"issue":"8","key":"4428_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5.","journal-title":"Protein Cell"},{"key":"4428_CR15","doi-asserted-by":"publisher","unstructured":"Li S, Lu Z, Sun R, et al. The Role of SLC7A11 in Cancer: Friend or Foe? Cancers (Basel). 2022;14(13). https:\/\/doi.org\/10.3390\/cancers14133059.","DOI":"10.3390\/cancers14133059"},{"issue":"10","key":"4428_CR16","first-page":"3106","volume":"10","author":"W Lin","year":"2020","unstructured":"Lin W, Wang C, Liu G, et al. SLC7A11\/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020;10(10):3106\u201326.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4428_CR17","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q, et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun. 2023;14(1):3673. https:\/\/doi.org\/10.1038\/s41467-023-39401-9.","journal-title":"Nat Commun"},{"issue":"4","key":"4428_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","volume":"39","author":"MR Liu","year":"2021","unstructured":"Liu MR, Zhu WT, Pei DS. System Xc(-): a key regulatory target of ferroptosis in cancer. Invest New Drugs. 2021;39(4):1123\u201331. https:\/\/doi.org\/10.1007\/s10637-021-01070-0.","journal-title":"Invest New Drugs"},{"issue":"5","key":"4428_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"1","key":"4428_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34. https:\/\/doi.org\/10.1186\/s13045-019-0720-y.","journal-title":"J Hematol Oncol"},{"issue":"21","key":"4428_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.21037\/atm-20-2554a","volume":"8","author":"R Tang","year":"2020","unstructured":"Tang R, Hua J, Xu J, et al. The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer. Ann Transl Med. 2020;8(21):1347. https:\/\/doi.org\/10.21037\/atm-20-2554a.","journal-title":"Ann Transl Med"},{"issue":"7","key":"4428_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4428_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jviscsurg.2013.10.001","volume":"151","author":"F Fiteni","year":"2014","unstructured":"Fiteni F, Westeel V, Pivot X, et al. Endpoints in cancer clinical trials. J Visc Surg. 2014;151(1):17\u201322. https:\/\/doi.org\/10.1016\/j.jviscsurg.2013.10.001.","journal-title":"J Visc Surg"},{"issue":"27","key":"4428_CR24","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1200\/jco.2016.66.6198","volume":"34","author":"Y Deng","year":"2016","unstructured":"Deng Y, Chi P, Lan P, et al. Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial. J Clin Oncol. 2016;34(27):3300\u20137. https:\/\/doi.org\/10.1200\/jco.2016.66.6198.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4428_CR25","doi-asserted-by":"publisher","first-page":"e780","DOI":"10.1002\/onco.13707","volume":"26","author":"HY Chen","year":"2021","unstructured":"Chen HY, Feng LL, Li M, et al. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer. Oncologist. 2021;26(5):e780\u201393. https:\/\/doi.org\/10.1002\/onco.13707.","journal-title":"Oncologist"},{"key":"4428_CR26","unstructured":"Edition S, Edge S, Byrd D. AJCC cancer staging manual. AJCC cancer staging manual; 2017."},{"issue":"10","key":"4428_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/jcp.50.10.801","volume":"50","author":"PJ van Diest","year":"1997","unstructured":"van Diest PJ, van Dam P, Henzen-Logmans SC, et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. J Clin Pathol. 1997;50(10):801\u20134. https:\/\/doi.org\/10.1136\/jcp.50.10.801.","journal-title":"J Clin Pathol"},{"issue":"1","key":"4428_CR28","doi-asserted-by":"publisher","first-page":"20869","DOI":"10.1038\/s41598-023-47971-3","volume":"13","author":"A Want","year":"2023","unstructured":"Want A, Staniak K, Grabowska-Pyrzewicz W, et al. Optimized RT-qPCR and a novel normalization method for validating circulating miRNA biomarkers in ageing-related diseases. Sci Rep. 2023;13(1):20869. https:\/\/doi.org\/10.1038\/s41598-023-47971-3.","journal-title":"Sci Rep"},{"key":"4428_CR29","doi-asserted-by":"publisher","unstructured":"Yuan Z, Hu J, Cai C, et al. Integrated network pharmacology and experimental verification to reveal the mechanisms of curcumin in the treatment of colorectal cancer. Front Pharmacol. 2026;16\u20132025. https:\/\/doi.org\/10.3389\/fphar.2025.1703562.","DOI":"10.3389\/fphar.2025.1703562"},{"key":"4428_CR30","doi-asserted-by":"publisher","first-page":"1085581","DOI":"10.3389\/fonc.2023.1085581","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, Xiao B, Chen W, et al. The potential of ferroptosis combined with radiotherapy in cancer treatment. Front Oncol. 2023;13:1085581. https:\/\/doi.org\/10.3389\/fonc.2023.1085581.","journal-title":"Front Oncol"},{"key":"4428_CR31","doi-asserted-by":"publisher","first-page":"e14931","DOI":"10.7717\/peerj.14931","volume":"11","author":"J Wang","year":"2023","unstructured":"Wang J, Hao S, Song G, et al. The prognostic and clinicopathological significance of SLC7A11 in human cancers: a systematic review and meta-analysis. PeerJ. 2023;11:e14931. https:\/\/doi.org\/10.7717\/peerj.14931.","journal-title":"PeerJ"},{"key":"4428_CR32","doi-asserted-by":"publisher","first-page":"770857","DOI":"10.3389\/fgene.2021.770857","volume":"12","author":"J He","year":"2021","unstructured":"He J, Ding H, Li H, et al. Intra-Tumoral Expression of SLC7A11 Is Associated with Immune Microenvironment, Drug Resistance, and Prognosis in Cancers: A Pan-Cancer Analysis. Front Genet. 2021;12:770857. https:\/\/doi.org\/10.3389\/fgene.2021.770857.","journal-title":"Front Genet"},{"issue":"1","key":"4428_CR33","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1038\/s41598-023-45284-z","volume":"13","author":"Q Shan","year":"2023","unstructured":"Shan Q, Zhang C, Li Y, et al. SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma. Sci Rep. 2023;13(1):18302. https:\/\/doi.org\/10.1038\/s41598-023-45284-z.","journal-title":"Sci Rep"},{"issue":"2","key":"4428_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/1471-0528.17327","volume":"129","author":"X Wu","year":"2022","unstructured":"Wu X, Shen S, Qin J, et al. High co-expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer. BJOG. 2022;129(2):40\u20139. https:\/\/doi.org\/10.1111\/1471-0528.17327.","journal-title":"BJOG"},{"key":"4428_CR35","doi-asserted-by":"publisher","first-page":"1012505","DOI":"10.3389\/fmolb.2022.1012505","volume":"9","author":"Y Liang","year":"2022","unstructured":"Liang Y, Su S, Lun Z, et al. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. Front Mol Biosci. 2022;9:1012505. https:\/\/doi.org\/10.3389\/fmolb.2022.1012505.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"4428_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41419-022-04827-4","volume":"13","author":"B Tang","year":"2022","unstructured":"Tang B, Zhu J, Liu F, et al. xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT\/mTOR cascade. Cell Death Dis. 2022;13(4):373. https:\/\/doi.org\/10.1038\/s41419-022-04827-4.","journal-title":"Cell Death Dis"},{"key":"4428_CR37","doi-asserted-by":"publisher","first-page":"889688","DOI":"10.3389\/fmolb.2022.889688","volume":"9","author":"X Cheng","year":"2022","unstructured":"Cheng X, Wang Y, Liu L, et al. SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma. Front Mol Biosci. 2022;9:889688. https:\/\/doi.org\/10.3389\/fmolb.2022.889688.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"4428_CR38","first-page":"677","volume":"35","author":"K Sugano","year":"2015","unstructured":"Sugano K, Maeda K, Ohtani H, et al. Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer. Anticancer Res. 2015;35(2):677\u201382.","journal-title":"Anticancer Res"},{"issue":"22","key":"4428_CR39","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41388-024-02996-4","volume":"43","author":"N Cao","year":"2024","unstructured":"Cao N, Zhang F, Yin J, et al. LPCAT2 inhibits colorectal cancer progression via the PRMT1\/SLC7A11 axis. Oncogene. 2024;43(22):1714\u201325. https:\/\/doi.org\/10.1038\/s41388-024-02996-4.","journal-title":"Oncogene"},{"issue":"1","key":"4428_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12967-025-06378-6","volume":"23","author":"M Jin","year":"2025","unstructured":"Jin M, Liu H, Zheng Z, et al. CHI3L1 mediates radiation resistance in colorectal cancer by inhibiting ferroptosis via the p53\/SLC7A11 pathway. J Transl Med. 2025;23(1):357. https:\/\/doi.org\/10.1186\/s12967-025-06378-6.","journal-title":"J Transl Med"},{"issue":"1","key":"4428_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41420-024-01993-6","volume":"10","author":"W Liu","year":"2024","unstructured":"Liu W, Liu C, Xiao J, et al. HTRA1 interacts with SLC7A11 to modulate colorectal cancer chemosensitivity by inhibiting ferroptosis. Cell Death Discovery. 2024;10(1):228. https:\/\/doi.org\/10.1038\/s41420-024-01993-6.","journal-title":"Cell Death Discovery"},{"key":"4428_CR42","doi-asserted-by":"publisher","first-page":"772380","DOI":"10.3389\/fcell.2021.772380","volume":"9","author":"R Liu","year":"2021","unstructured":"Liu R, Liu L, Bian Y, et al. The Dual Regulation Effects of ESR1\/NEDD4L on SLC7A11 in Breast Cancer Under Ionizing Radiation. Front Cell Dev Biol. 2021;9:772380. https:\/\/doi.org\/10.3389\/fcell.2021.772380.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4428_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12967-021-03042-7","volume":"19","author":"L Feng","year":"2021","unstructured":"Feng L, Zhao K, Sun L, et al. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med. 2021;19(1):367. https:\/\/doi.org\/10.1186\/s12967-021-03042-7.","journal-title":"J Transl Med"},{"issue":"1","key":"4428_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12935-023-03091-6","volume":"23","author":"T Liu","year":"2023","unstructured":"Liu T, Ren Y, Wang Q, et al. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. Cancer Cell Int. 2023;23(1):259. https:\/\/doi.org\/10.1186\/s12935-023-03091-6.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"4428_CR45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neo.2021.11.002","volume":"23","author":"W Huang","year":"2021","unstructured":"Huang W, Chen K, Lu Y, et al. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia. 2021;23(12):1227\u201339. https:\/\/doi.org\/10.1016\/j.neo.2021.11.002.","journal-title":"Neoplasia"},{"issue":"1","key":"4428_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zheng W, Guan J, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 2023;30(1):137\u201351. https:\/\/doi.org\/10.1038\/s41418-022-01051-7.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4428_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves F, Lane D, Nguyen TPM, et al. In defence of ferroptosis. Signal Transduct Target Therapy. 2025;10(1):2. https:\/\/doi.org\/10.1038\/s41392-024-02088-5.","journal-title":"Signal Transduct Target Therapy"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04428-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:01:57Z","timestamp":1792591317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04428-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4428"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04428-7","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Review Committee of the Sixth Affiliated Hospital of Sun Yat-sen University (Approval No. 2022ZSLYEC-137). All procedures followed institutional guidelines under the committee\u2019s supervision.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"344"}}